What is Immunome's change in other assets?

Immunome (IMNM) reported change in other assets of $5.1M in Q1 2026.

How has Immunome's change in other assets changed year-over-year?

Immunome's change in other assets increased by 198.7% year-over-year, from $1.71M to $5.1M.

What is the long-term trend for Immunome's change in other assets?

Over 2 years (2021 to 2023), Immunome's change in other assets has grown at a -1.6% compound annual growth rate (CAGR), from $4.28M to $4.14M.

What does change in other assets mean?

Change in miscellaneous assets affecting operating cash flow.

Immunome IMNM Change in Other Assets

Change in Other Assets at other companies

PfizerPFE

-$322.25M+61.9%

Arcus BiosciencesRCUS

$3M—

Nuvation BioNUVB

-$3.78M-2,509%

SELLAS Life Sciences Group, Inc.SLS

$652K-42.4%

IDEAYA Biosciences, Inc.IDYA

-$3.03M-254%

ImmunityBio, Inc.IBRX

$1.05M+1,152%

Other financials

Income statement

See full

Revenue--100%

Operating income-$59.3M-32.9%

Net income-$53.8M-29.3%

EPS (diluted)-$0.48+7.7%

Balance sheet

See full

Cash & equivalents$582.7M+126%

Total debt$3.7M-22.6%

Total equity$588.7M+91.7%

Total assets$619.8M+80.9%

Cash flow

See full

Operating cash flow-$58.6M-10.5%

CapEx$3.0M-18.1%

Free cash flow-$61.6M-8.7%

Valuation

See full

Market cap$2.19B+323%

Enterprise value$1.61B+470%

P/S545.2×+498×

Profitability

See full

Operating margin-5,947.9%-12,002pp

Net margin-5,593.8%-11,284pp

FCF margin-5,118.9%-8,601pp

Returns & leverage

See full

Return on equity-50.1%-10.8pp

Debt / equity0×0.0×

Current ratio21.7×+11.2×

Where this comes from

Reported directly by Immunome in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunome's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immunome's change in other assets?: Immunome (IMNM) reported change in other assets of $5.1M in Q1 2026.
How has Immunome's change in other assets changed year-over-year?: Immunome's change in other assets increased by 198.7% year-over-year, from $1.71M to $5.1M.
What is the long-term trend for Immunome's change in other assets?: Over 2 years (2021 to 2023), Immunome's change in other assets has grown at a -1.6% compound annual growth rate (CAGR), from $4.28M to $4.14M.
What does change in other assets mean?: Change in miscellaneous assets affecting operating cash flow.